These inconsistencies could be due to age of the study animals, however, because levels of IGF-2 in the PZ consistently decrease with age, whereas IGF-1 levels increase after birth [156]
"In our clinical trials, Cagrilintide has provided substantial weight loss, in a distinct manner compared to approved obesity medications, and appears well-tolerated," Martin Holst Lange, Novo Nordisk's chief scientific officer and executive vice president of research and development, said in a statement
Clinical trials paired semaglutide with reduced-calorie diets (approximately 500 calories below maintenance) and 150 minutes of weekly physical activity
It has been studied for its potential to support tissue repair, reduce inflammation, and promote healing throughout the body